[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.209.104.7. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 19, 1957

ISONIAZID IN TREATMENT OF MULTIPLE SCLEROSIS

Author Affiliations

White Plains, N. Y.

From the Section on Neurology, Veterans Administration Hospital, Bronx, N. Y. Dr. Kurtzke is now at the Veterans Administration Hospital, Coatesville, Pa.

JAMA. 1957;163(3):172-174. doi:10.1001/jama.1957.02970380014005
Abstract

• The clinical results of therapy with isoniazid for multiple sclerosis, while effecting subjective and objective improvement in a large percentage of cases, cannot be considered significant. New exacerbations continued to occur whether or not isoniazid therapy was continued. It has been established, however, that it is possible to evaluate therapy in this disease, in a reasonably short time, if the disease is manifested by progressing dysfunction, if the study is done on concurrently observed patients with comparable illnesses, and if a double-blind procedure is utilized.

×